Quick Answer
Senti Biosciences Holdings, Inc. reported Total Assets of $51.22 million for fiscal year 2025.
Senti Biosciences Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $51.22M | -47.6% |
| 2024 | $97.84M | -18.1% |
| 2023 | $119.48M | -33.9% |
| 2022 | $180.79M | +87.0% |
| 2021 | $96.70M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $52.69M | -8.7% | -23.1% |
| June 30, 2025 | $68.54M | -21.1% | -17.2% |
| March 31, 2025 | $82.78M | -19.0% | -15.4% |
| December 31, 2024 | $97.84M | -18.1% | +69.5% |
| September 30, 2024 | $57.72M | -56.2% | -33.6% |
| June 30, 2024 | $86.91M | -39.5% | -14.9% |
| March 31, 2024 | $102.19M | -36.7% | -14.5% |
| December 31, 2023 | $119.48M | -33.9% | -9.3% |
- Senti Biosciences Holdings, Inc. showed a decrease of -47.6% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Senti Biosciences Holdings, Inc.’s total assets has declined by 47.0% (from $96.70 million to $51.22 million).
- The most recent figure is from Senti Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: